MedPath

Directly Observed antiretroviral Therapy for people living with Human Immunodeficiency Virus (HIV) and Acquired ImmunDeficiency Syndrome (AIDS): a randomised controlled trial

Completed
Conditions
HIV/AIDS
Infections and Infestations
Registration Number
ISRCTN48682427
Lead Sponsor
Ministry of Health (Brazil)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. HIV-1 infected individuals
2. 18 years old or older
3. Starting antiretroviral therapy in three AIDS clinics in Porto Alegre (Brazil)

Exclusion Criteria

Not provided at time of registration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Adherence to highly active antiretroviral therapy (HAART) at the end of the study (6 months)<br>2. Diseases progression <br>3. Occurence of AIDS-related disease/opportunistic infections
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath